Fig. 1From: Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world studySurvival outcomes for patients treated with CCRT or RT after PCT. A OS for all patients. B OS for propensity score-matched patients. C PFS, including LRPFS and DPFS for propensity score-matched patients. CCRT concurrent chemoradiotherapy, RT radiotherapy, PCT palliative chemotherapy, OS overall survival, PFS progression-free survival, LRPFS locoregional progression-free survival, DPFS distant progression-free survivalBack to article page